Drug Shortage Report for DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION
Report ID | 221282 |
Drug Identification Number | 02464381 |
Brand name | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION |
Common or Proper name | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXMEDETOMIDINE |
Strength(s) | 100MCG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 2ML |
ATC code | N05CM |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-03-04 |
Estimated end date | 2024-04-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-03-05 | English | Compare |
v2 | 2024-03-04 | French | Compare |
v1 | 2024-03-04 | English | Compare |
Showing 1 to 3 of 3